New 'fatal' warning for anyone on dapagliflozin, empagliflozin or canagliflozin

NewsHealthHealthMore than a million people take the drugs every dayNeil Shaw Assistant Editor (Money and Lifestyle)06:48, 02 Sep 2026Researchers have issued a new alert over a common pill taken by more than 1million people in the UK. The medication is commonly prescribed to people with type 2 diabetes and a third of those with the condition have the drugs.‌New research has highlighted the link between ketoacidosis and SGLT2 inhibitors such as dapagliflozin , empagliflozin , canagliflozin , and ertugliflozin. Ketoacidosis occurs when harmful ketones build-up in the blood, triggering a life-threatening 'attack'. Swedish researchers say the complication could be more common in people taking the drug if they have low body weight.‌That could be around 10 per cent of those taking the pills. Sepa